Cargando…

Metabolic Syndrome and Psoriasis: A Case–Control Study in Kabul, Afghanistan

BACKGROUND: Psoriasis is a chronic inflammatory disease that is not limited to the skin. Recently, numerous studies have shown a positive association between metabolic syndrome and psoriasis. OBJECTIVE: The current study aimed to examine the association of metabolic syndrome with psoriasis in an Afg...

Descripción completa

Detalles Bibliográficos
Autores principales: Aalemi, Ahmad Khalid, Bahain, Mohammad Barin, Hamdard, Abdul Ghafar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019617/
https://www.ncbi.nlm.nih.gov/pubmed/33833537
http://dx.doi.org/10.2147/DMSO.S305806
_version_ 1783674409956933632
author Aalemi, Ahmad Khalid
Bahain, Mohammad Barin
Hamdard, Abdul Ghafar
author_facet Aalemi, Ahmad Khalid
Bahain, Mohammad Barin
Hamdard, Abdul Ghafar
author_sort Aalemi, Ahmad Khalid
collection PubMed
description BACKGROUND: Psoriasis is a chronic inflammatory disease that is not limited to the skin. Recently, numerous studies have shown a positive association between metabolic syndrome and psoriasis. OBJECTIVE: The current study aimed to examine the association of metabolic syndrome with psoriasis in an Afghan population. METHODS: This was a case– control study including 114 patients with psoriasis and 114 controls aged ≥18 years admitted to the dermatology department of Maiwand Teaching Hospital in Kabul, Afghanistan. Height, weight, blood pressure, and waist circumference were measured in all subjects. Blood glucose, triglyceride, cholesterol, and high-density lipoprotein cholesterol levels were tested following overnight fasting. The modified National Cholesterol Education Program – Adult Treatment Panel III criteria were used for the diagnosis of metabolic syndrome. RESULTS: In total, 51.8% of the cases and 44.7% of the controls were male. The average age of participants was 33.4±13.1 years in the case group and 41.1±15.4 years in the control group. The average duration of disease for psoriasis was 4.2 years with 5.6 years SD. The average PASI was 10.8 with 5.1 SD. More than half of the cases (62.3%) had moderate to severe psoriasis and 37.7% had mild psoriasis. The prevalence of metabolic syndrome was higher among patients with psoriasis compared to controls (36.8% vs 21.1%) with OR of 2.18 (p=0.009). In addition, overweight/obesity was more prevalent among cases compared to controls (65.8% vs 41.2%) with OR of 2.74 (p<0.001), whereas the waist circumference was not significantly different between the two groups. Furthermore, the mean levels of total cholesterol, triglyceride, and fasting blood glucose were also higher among patients with psoriasis compared to controls. CONCLUSION: The results of the study confirm the association between psoriasis and metabolic syndrome. Hence, screening psoriatic patients for metabolic syndrome should be considered.
format Online
Article
Text
id pubmed-8019617
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-80196172021-04-07 Metabolic Syndrome and Psoriasis: A Case–Control Study in Kabul, Afghanistan Aalemi, Ahmad Khalid Bahain, Mohammad Barin Hamdard, Abdul Ghafar Diabetes Metab Syndr Obes Original Research BACKGROUND: Psoriasis is a chronic inflammatory disease that is not limited to the skin. Recently, numerous studies have shown a positive association between metabolic syndrome and psoriasis. OBJECTIVE: The current study aimed to examine the association of metabolic syndrome with psoriasis in an Afghan population. METHODS: This was a case– control study including 114 patients with psoriasis and 114 controls aged ≥18 years admitted to the dermatology department of Maiwand Teaching Hospital in Kabul, Afghanistan. Height, weight, blood pressure, and waist circumference were measured in all subjects. Blood glucose, triglyceride, cholesterol, and high-density lipoprotein cholesterol levels were tested following overnight fasting. The modified National Cholesterol Education Program – Adult Treatment Panel III criteria were used for the diagnosis of metabolic syndrome. RESULTS: In total, 51.8% of the cases and 44.7% of the controls were male. The average age of participants was 33.4±13.1 years in the case group and 41.1±15.4 years in the control group. The average duration of disease for psoriasis was 4.2 years with 5.6 years SD. The average PASI was 10.8 with 5.1 SD. More than half of the cases (62.3%) had moderate to severe psoriasis and 37.7% had mild psoriasis. The prevalence of metabolic syndrome was higher among patients with psoriasis compared to controls (36.8% vs 21.1%) with OR of 2.18 (p=0.009). In addition, overweight/obesity was more prevalent among cases compared to controls (65.8% vs 41.2%) with OR of 2.74 (p<0.001), whereas the waist circumference was not significantly different between the two groups. Furthermore, the mean levels of total cholesterol, triglyceride, and fasting blood glucose were also higher among patients with psoriasis compared to controls. CONCLUSION: The results of the study confirm the association between psoriasis and metabolic syndrome. Hence, screening psoriatic patients for metabolic syndrome should be considered. Dove 2021-03-30 /pmc/articles/PMC8019617/ /pubmed/33833537 http://dx.doi.org/10.2147/DMSO.S305806 Text en © 2021 Aalemi et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Aalemi, Ahmad Khalid
Bahain, Mohammad Barin
Hamdard, Abdul Ghafar
Metabolic Syndrome and Psoriasis: A Case–Control Study in Kabul, Afghanistan
title Metabolic Syndrome and Psoriasis: A Case–Control Study in Kabul, Afghanistan
title_full Metabolic Syndrome and Psoriasis: A Case–Control Study in Kabul, Afghanistan
title_fullStr Metabolic Syndrome and Psoriasis: A Case–Control Study in Kabul, Afghanistan
title_full_unstemmed Metabolic Syndrome and Psoriasis: A Case–Control Study in Kabul, Afghanistan
title_short Metabolic Syndrome and Psoriasis: A Case–Control Study in Kabul, Afghanistan
title_sort metabolic syndrome and psoriasis: a case–control study in kabul, afghanistan
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019617/
https://www.ncbi.nlm.nih.gov/pubmed/33833537
http://dx.doi.org/10.2147/DMSO.S305806
work_keys_str_mv AT aalemiahmadkhalid metabolicsyndromeandpsoriasisacasecontrolstudyinkabulafghanistan
AT bahainmohammadbarin metabolicsyndromeandpsoriasisacasecontrolstudyinkabulafghanistan
AT hamdardabdulghafar metabolicsyndromeandpsoriasisacasecontrolstudyinkabulafghanistan